Results 11 to 20 of about 42,547 (218)
Clinical and translational research in Pneumocystis and Pneumocystis pneumonia* [PDF]
Pneumocystis pneumonia (PcP) remains a significant cause of morbidity and mortality in immunocompromised persons, especially those with human immunodeficiency virus (HIV) infection.
Huang L.
doaj +7 more sources
Nosocomial Pneumocystis jirovecii infections
Airborne transmission of Pneumocystis sp. from host to host has been demonstrated in rodent models and several observations suggest that interindividual transmission occurs in humans.
Nevez G. +6 more
doaj +4 more sources
Transmission de Pneumocystis = Pneumocystis transmission
star, openConférence présentée au Symposium « Pneumocystis et pneumocystose 100 ans après », présidence Patricia Roux et Eduardo Dei-Cas, faculté de médecine Necker, Paris le 29 novembre 2008. Congrès SFMM – 29 novembre 2008, Paris/Congress of the French
E. Dei-Cas +13 more
core +4 more sources
Since its initial misidentification as a trypanosome some 100 years ago, Pneumocystis has remained recalcitrant to study. Although we have learned much, we still do not have definitive answers to such basic questions as, where is the reservoir of infection, how does Pneumocystis reproduce, what is the mechanism of infection, and are there true species ...
Francis, Gigliotti +2 more
openaire +2 more sources
Pneumocystis carinii is an atypical fungus that causes pneumonia in immunocompromised individuals. P. carinii comprises a heterogeneous group of organisms that have been isolated from a wide range of mammalian host species. P. carinii infection is host species specific, the P. carinii organisms that infect humans have only been found in humans.
openaire +4 more sources
CAQ Corner: Immune‐mediated complications
Liver Transplantation, EarlyView.
Mary Thomson, John R. Lake
wiley +1 more source
Dihydropteroate synthase gene mutations in Pneumocystis and sulfa resistance [PDF]
Pneumocystis pneumonia (PCP) remains a major cause of illness and death in HIV-infected persons. Sulfa drugs, trimethoprim-sulfamethoxazole (TMP-SMX) and dapsone are mainstays of PCP treatment and prophylaxis.
Meja Rabodonirina +20 more
core +1 more source
Genotypic variation in Pneumocystis jirovecii isolates in Britain [PDF]
Background: Pneumocystis jirovecii is the cause of Pneumocystis pneumonia (PCP) in immunosuppressed humans. Asymptomatic colonisation with P jirovecii may occur in patients with minor immunosuppression or chronic lung disease.
Davies, RJ +6 more
core +1 more source
Increasing Pneumocystis pneumonia, England, UK, 2000-2010. [PDF]
After an increase in the number of reported cases of Pneumocystis jirovecii pneumonia in England, we investigated data from 2000-2010 to verify the increase. We analyzed national databases for microbiological and clinical diagnoses of P.
Nichols, Gordon +13 more
core +1 more source

